dormizol
sanofi-aventis australia pty ltd - zolpidem tartrate -
temizole
aspen pharma pty ltd - temozolomide -
mizollen 10 mg tabl. modif.-rel.
opella healthcare belgium sa-nv - mizolastine 10 mg - modified-release tablet - 10 mg - mizolastine 10 mg - mizolastine
novalgine 500 mg/ml oral drops sol.
opella healthcare belgium sa-nv - metamizole sodium 500 mg/ml - oral drops, solution - 500 mg/ml - metamizole sodium 500 mg/ml - metamizole sodium
novalgine 500 mg film-coat. tabl.
opella healthcare belgium sa-nv - metamizole sodium 500 mg - film-coated tablet - 500 mg - metamizole sodium 500 mg - metamizole sodium
novalgine 1000 mg/2 ml inj. sol. i.m./i.v. amp.
opella healthcare belgium sa-nv - metamizole sodium 1000 mg/2 ml - solution for injection - 1000 mg/2 ml - metamizole sodium 1000 mg - metamizole sodium
rivalgin 500 mg/ml inj. sol. i.v./i.m. vial
richter pharma ag - metamizole sodium monohydrate 500 mg/ml - eq. noramidopyrine 443,1 mg/ml - solution for injection - 500 mg/ml - metamizole sodium monohydrate 500 mg/ml - metamizole sodium - horse; cattle; pig; dog
vetalgin inj. sol. i.m./i.v. vial
intervet international - metamizole sodium 500 mg/ml - solution for injection - metamizole sodium 500 mg/ml - metamizole sodium - cattle; horse; pig
temizole 180 temozolomide 180 mg capsule bottle
viatris pty ltd - temozolomide, quantity: 180 mg - capsule, hard - excipient ingredients: tartaric acid; stearic acid; lactose; iron oxide yellow; purified water; sodium starch glycollate; gelatin; titanium dioxide; iron oxide red; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,treatment of recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as a first-line treatment for patients with advanced metastatic malignant melanoma.
dipyrone kalceks 500 mgml
a.l. medi-market ltd. - metamizole sodium monohydrate - solution for injection - metamizole sodium monohydrate 500 mg / 1 ml - metamizole sodium - as an analgesic: dypirone kalceks, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. as an antipyretic: dypirone kalceks by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision